J. Monen
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 8
-
- Antibiotic Use and Resistance 6
- Co-authors
- Hajo Grundmann (11 shared papers)Edine W. Tiemersma (8 shared papers)Marlieke E.A. de Kraker (6 shared papers)Nienke van de Sande-Bruinsma (6 shared papers)Vincent Jarlier (4 shared papers)Ole Eske Heuer (4 shared papers)Nienke Bruinsma (3 shared papers)Stef L.A.M. Bronzwaer (3 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Eurosurveillance (5 papers)Clinical Microbiology and Infection (4 papers)Emerging infectious diseases (3 papers)PLoS ONE (3 papers)
- Partner nations
- NetherlandsSwedenFrance
In The Last Decade
J. Monen
28 papers receiving 4.3k citations
J. Monen's Hit Papers
Peers
Comparison fields: 5 of 155
- Applied Microbiology and Biotechnology 1.2k
- Molecular Medicine 1.3k
- Clinical Biochemistry 708
- Infectious Diseases 1.1k
- Microbiology 260
Countries citing papers authored by J. Monen
This map shows the geographic impact of J. Monen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Monen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Monen more than expected).
Fields of papers citing papers by J. Monen
This network shows the impact of papers produced by J. Monen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Monen. The network helps show where J. Monen may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Monen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis Hit paper breakdown → | 2018 | 2392 |
| 2 | 2004 | 455 | |
| 3 | 2008 | 401 | |
| 4 | 2012 | 317 | |
| 5 | 2011 | 167 | |
| 6 | 2007 | 127 | |
| 7 | 2004 | 58 | |
| 8 | 2006 | 57 | |
| 9 | 2013 | 53 | |
| 10 | 2009 | 51 | |
| 11 | 2021 | 44 | |
| 12 | 2014 | 35 | |
| 13 | 1994 | 28 | |
| 14 | 2019 | 27 | |
| 15 | 2022 | 25 | |
| 16 | 2005 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2008 | 19 | |
| 19 | 2012 | 19 | |
| 20 | 2017 | 17 |
About J. Monen
J. Monen is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Infectious Diseases and Epidemiology, having authored 28 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (11 papers), Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antibiotic Use and Resistance (6 papers), Pneumonia and Respiratory Infections (4 papers), Neutropenia and Cancer Infections (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Urinary Tract Infections Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.2k citations), Molecular Medicine (1.3k citations), Clinical Biochemistry (708 citations), Infectious Diseases (1.1k citations) and Microbiology (260 citations). J. Monen has collaborated with scholars based in Netherlands, Sweden and France. Frequent co-authors include Hajo Grundmann, Edine W. Tiemersma, Marlieke E.A. de Kraker, Nienke van de Sande-Bruinsma, Vincent Jarlier, Ole Eske Heuer, Nienke Bruinsma, Stef L.A.M. Bronzwaer, John E. Degener and Matus Ferech. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Eurosurveillance, Clinical Microbiology and Infection, Emerging infectious diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.